Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Severe CCCA may be biologically and clinically different from milder forms.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Dermatoscopy can help diagnose CCCA without visible hair loss, offering a less invasive option than biopsy.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

Autologous fat transfer improves hair growth in scarring alopecia and allows for denser hair transplants.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

CCCA causes progressive hair loss in Black women, starting from a central scalp patch.

CCCA may be caused by both hair traction and an immune response.

Genetic factors, especially PADI3 gene variants, contribute to CCCA in women of African descent.

Genetic variants in specific genes cause central centrifugal cicatricial alopecia.

There is no standard treatment for CCCA, and practices vary widely.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Low-dose metformin may help hair regrowth and reduce inflammation in CCCA.

Topical metformin 10% cream may help treat central centrifugal cicatricial alopecia.

Allergens might contribute to CCCA, so avoiding them could help manage the condition.

Men with CCCA often face delayed diagnosis and severe hair loss, highlighting the need for earlier recognition and treatment.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

CCCA affects Black men too, with a genetic link found in the PADI3 gene.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

DNA analysis can help tailor alopecia treatment.